Biogen, Inc. (BIIB)
175.60
-4.94
(-2.74%)
USD |
NASDAQ |
Apr 16, 15:20
Biogen Price : 175.60 for April 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 348.70 |
| Gilead Sciences, Inc. | 138.59 |
| Johnson & Johnson | 233.87 |
| Apellis Pharmaceuticals, Inc. | 40.88 |
| Moderna, Inc. | 54.16 |
Price Related Metrics
| PE Ratio | 19.94 |
| PS Ratio | 2.704 |
| Price to Book Value | 1.412 |
| Price to Free Cash Flow | 13.09 |
| Earnings Yield | 5.01% |
| Market Cap | 25.77B |
| Operating PE Ratio | 10.65 |
| Normalized PE Ratio | 15.06 |